Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Akums Drugs & Pharmaceuticals is India's largest contract development and manufacturing organization (CDMO), providing a comprehensive suite of pharmaceutical solutions to global and domestic markets. The company specializes in the formulation, development, and manufacturing of a wide array of dosage forms, including oral solids, liquid orals, injectables, and specialized delivery systems like hormonal and oncology products. Akums operates numerous state-of-the-art manufacturing facilities, many of which hold international regulatory approvals such as WHO-GMP and various country-specific certifications. Serving as a backbone to the Indian pharma industry, the company partners with most of the top pharmaceutical firms in India and several global players. Their business model is driven by robust R&D capabilities, allowing them to offer over 4,000 formulations across multiple therapeutic areas. Recently listed on the Indian stock exchanges, Akums continues to expand its global footprint and manufacturing excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Akums Pharmaceuticals.